Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CG | P48736 | 1/20 | 0.66 |
| ▸ | NPC1 | O15118 | 8/20 | 0.61 |
| ▸ | RAB9A | P51151 | 8/20 | 0.61 |
| ▸ | MAPT | P10636 | 6/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.61 |
| ▸ | MEN1 | O00255 | 4/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.61 |
| ▸ | HPGD | P15428 | 3/20 | 0.61 |
| ▸ | GLA | P06280 | 1/20 | 0.61 |
| ▸ | GAA | P10253 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.43 |
| ▸ | LCK | P06239 | 1/20 | 0.43 |
| ▸ | GFER | P55789 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6398262 | 0.83 | MAPT (0.66) | PIK3CGNPC1RAB9AMAPTSMN1; SMN2 | |
| SCHEMBL10950114 | 0.83 | PIK3CG (0.66) | PIK3CGNPC1RAB9AMAPTSMN1; SMN2 | |
| SCHEMBL15157800 | 0.79 | NPC1 (0.58) | PIK3CGNPC1RAB9AMAPTSMN1; SMN2 | |
| SCHEMBL9898426 | 0.79 | PIK3CG (0.61) | PIK3CGNPC1RAB9AMAPTSMN1; SMN2 | |
| SCHEMBL557792 | 0.79 | PIK3CG (0.61) | PIK3CGNPC1RAB9AMAPTSMN1; SMN2 | |
| SCHEMBL9896463 | 0.79 | PIK3CG (1.00) | PIK3CGNPC1RAB9AMAPTSMN1; SMN2 | |
| SCHEMBL7893733 | 0.79 | PIK3CG (0.61) | PIK3CGNPC1RAB9AMAPTSMN1; SMN2 | |
| SCHEMBL30988526 | 0.79 | PIK3CG (0.61) | PIK3CGNPC1RAB9AMAPTSMN1; SMN2 | |
| SCHEMBL21983971 | 0.79 | PIK3CG (0.61) | PIK3CGNPC1RAB9AMAPTSMN1; SMN2 | |
| SCHEMBL615340 | 0.79 | SMN1; SMN2 (0.58) | PIK3CGNPC1RAB9AMAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025085329-A1 | MULTIFUNCTIONAL ADHESION PROMOTER FOR SEMICONDUCTOR DEVICE PACKAGES | WOLFSPEED, INC. (US) | 2025-04-24 | — | — | WO | claimed |
| US-20250122413-A1 | Multifunctional Adhesion Promoter for Semiconductor Device Packages | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT | 2025-04-17 | — | — | US | claimed |
| CN-116333299-B | Preparation method of polyol for waterborne polyurethane | 上海蓝欧化工科技有限公司 | 2025-04-08 | — | — | CN | claimed |
| US-20240336599-A1 | PHOTOSENSITIVE POLYAMIC ACID AND DIAZIRINE COMPOSITIONS | PROMERUS, LLC (US) | 2024-10-10 | — | — | US | claimed |
| US-20240254284-A1 | UNSATURATED CYCLIC ANHYDRIDE END CAPPED POLYIMIDES AND POLYAMIC ACIDS AND PHOTOSENSITIVE COMPOSITIONS THEREOF | PROMERUS, LLC (US) | 2024-08-01 | — | — | US | claimed |
| WO-2020232338-A1 | POSITIVE TONE PHOTOSENSITIVE COMPOSITIONS CONTAINING AMIC ACID AS LATENT BASE CATALYST | PROMERUS, LLC (US) | 2020-11-19 | — | — | WO | claimed |
| US-20200283580-A1 | UNSATURATED CYCLIC ANHYDRIDE END CAPPED POLYIMIDES AND POLYAMIC ACIDS AND PHOTOSENSITIVE COMPOSITIONS THEREOF | PROMERUS, LLC (US) | 2020-09-10 | — | — | US | claimed |
| US-20090170914-A1 | Cermide Kinase Modulation | BORNANCIN FREDERIC | 2009-07-02 | — | — | US | claimed |
| CN-101415695-A | Ceramide kinase modulation | NOVARTIS AG (CH) | 2009-04-22 | — | — | CN | claimed |
| EP-2004617-A2 | CERAMIDE KINASE MODULATION | Novartis AG (CH) | 2008-12-24 | — | — | EP | claimed |
| WO-2007112914-A2 | CERAMIDE KINASE MODULATION | NOVARTIS AG (CH) | 2007-10-11 | — | — | WO | claimed |
| WO-2025085329-A1 | MULTIFUNCTIONAL ADHESION PROMOTER FOR SEMICONDUCTOR DEVICE PACKAGES | WOLFSPEED, INC. (US) | 2025-04-24 | — | — | WO | disclosed |
| US-20250122413-A1 | Multifunctional Adhesion Promoter for Semiconductor Device Packages | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT | 2025-04-17 | — | — | US | disclosed |
| CN-116333299-B | Preparation method of polyol for waterborne polyurethane | 上海蓝欧化工科技有限公司 | 2025-04-08 | — | — | CN | disclosed |
| US-20240336599-A1 | PHOTOSENSITIVE POLYAMIC ACID AND DIAZIRINE COMPOSITIONS | PROMERUS, LLC (US) | 2024-10-10 | — | — | US | disclosed |
| CN-101415695-A | Ceramide kinase modulation | NOVARTIS AG (CH) | 2009-04-22 | — | — | CN | disclosed |
| EP-2004617-A2 | CERAMIDE KINASE MODULATION | Novartis AG (CH) | 2008-12-24 | — | — | EP | disclosed |
| WO-2007112914-A2 | CERAMIDE KINASE MODULATION | NOVARTIS AG (CH) | 2007-10-11 | — | — | WO | disclosed |
| US-4321363-A | Adsorbent for urokinase containing agarose | NIPPON SODA COMPANY LIMITED (JP) | 1982-03-23 | — | — | US | disclosed |
| US-4122117-A | Indandione bis-azomethine pigments | DAINIPPON INK & CHEMICALS, INC. (JP) | 1978-10-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240336599-A1 | PHOTOSENSITIVE POLYAMIC ACID AND DIAZIRINE COMPOSITIONS | PUF60, FTO, PARN | PIK3CG 768/4885NPC1 4844/4885RAB9A 3650/4885 |
| US-20090170914-A1 | Cermide Kinase Modulation | CERS2, CHKB, SPHK2 | PIK3CG 483/4885NPC1 247/4885RAB9A 566/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.